P1181: REAL-LIFE TREATMENT APPROACHES AND THERAPY RESULTS IN THE PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA: POLISH-UKRAINIAN EXPERIENCE

por Filonenko, Kateryna, Szymańska, Agata, Stepanishyna, Yana, Shokun, Nazar, Skrypets, Tetiana, Federico, Massimo, Kryachok, Irina, Manni, Martina, Zaucha, Jan
Publicado 2023

Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification

por Kriachok, Iryna, Stepanishyna, Yana, Skrypets, Tetiana, Shokun, Nazar, Martynchyk, Arina, Tytorenko, Iryna, Aleksik, Olena, Krotevych, Mykhailo, Manni, Martina, Federico, Massimo
Publicado 2022

PB2125: VCD VERSUS VRD‐BASED REGIMENS AS INDUCTION THERAPIES IN PATIENTS WITH PRIMARY MULTIPLE MYELOMA (MM): HIGHLIGHTING STRATEGIES THAT ACTUALLY WORK.

por Novosad, Olga, Kriachok, Irina, Rudiuk, Tymur, Pastushenko, Ian, Tytorenko, Iryna, Aleksik, Olena, Shudrak, Natalia, Kadnikova, Tetiana, Horbach, Olexandr, Melnyk, Ulyana, Mykhalska, Larysa, Stepanishyna, Yana, Shokun, Nazar
Publicado 2023

The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

por Hapgood, Greg, Civallero, Monica, Stepanishyna, Yana, Vose, Julie, Cabrera, Monica Elena, Advani, Ranjana H., Pileri, Stefano A., Manni, Martina, Horwitz, Steven M., Foss, Francine M., Hitz, Felicitas, Radford, John, Dlouhy, Ivan, Chiattone, Carlos, Kim, Won Seog, Skrypets, Tetiana, Nagler, Arnon, Trotman, Judith, Luminari, Stefano, Federico, Massimo
Publicado 2023